Researchers from Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Harvard Medical School conducted a novel investigation into the minds of doctors, performing brain scans on physicians while they believed they were treating patients. Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, is the lead author.
As the clock ticks on Congress’ agreement to temporarily avert the fiscal cliff, the authors write that we must ensure any attempt at a resolution does not include drastic cuts to investments in early stage research, the fuel of Massachusetts’ economic engine. Massachusetts continues to be home to the top five NIH-funded independent hospitals: Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, and Boston Children’s Hospital.
A study shows physicians may care more than you think about their patients’ pain. Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, is the senior author of the study.
A new method to noninvasively diagnose cancer and monitor its progression could eliminate the need for painful and sometimes life-threatening biopsies. Fred Hochberg, HMS associate professor of neurology at Massachusetts General Hospital, is one of the researchers.
The nematode version of a gene central to mammalian hearing turns out to encode a salt sensor, according to new research. Jeffrey Holt, HMS associate professor of otology and laryngology at Boston Children’s Hospital, is quoted.
New research strongly reinforces the notion that prostate cancer is vastly overtreated with often dire results. Marc Garnick, HMS clinical professor of medicine at Beth Israel Deaconess Medical Center, is quoted.
Nancy Formella, a registered nurse and top administrator at Dartmouth-Hitchcock health system in Lebanon, N.H., will become chief operating officer of Beth Israel Deaconess Medical Center in March.
The National Football League players union is funding a 10-year, $100 million research project at Harvard Medical School to reduce the impact of on-the-field injuries and improve the long-term health of players. Lee Nadler, HMS dean for clinical and translational research, Virginia and D.K. Ludwig Professor of Medicine at Dana-Farber Cancer Institute and director of Harvard Catalyst, is the director of the new project. Ross Zafonte, Earl P. and Ida S. Charlton Professor and chair of physical medicine and rehabilitation at Spaulding Rehabilitation Hospital, Massachusetts General Hospital and chief of physical medicine and rehabilitation at Brigham and Women’s Hospital, is the co-director.
